Fibroblast EGFR signaling mediates ricin toxin-induced acute lung injury via EGR1/CXCL1 axis
Archives of Toxicology · 2025-08 · 99 (8) · 3413-3427
DOI: 10.1007/s00204-025-04067-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Toxicology, online erschienen am 03.05.2025. Verfasst von Yuqing Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, the Fifth Medical Center of PLA General Hospital, Beijing, 100039, China. Hauptthemen laut MEDLINE: ErbB Receptors, Acute Lung Injury, Early Growth Response Protein 1, Ricin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: he State Key Laboratory of Pathogen and Biosecurity.
Abstract (Originalsprache)
Ricin toxin (RT), a highly potent plant-derived toxin, represents a critical threat due to its capacity to induce fatal acute lung injury (ALI) upon inhalation. While the epidermal growth factor receptor (EGFR), a receptor tyrosine kinase predominantly expressed on epithelial cells and fibroblasts, regulates cellular processes such as growth, proliferation, differentiation and inflammation, its involvement in RT-induced ALI remains unexplored. This study investigates this relationship using a mouse model of ALI induced by aerosolized RT at a dose of 2.0 × LD50 (approximately 0.01 mg kg -1). The results demonstrate that damage to alveolar epithelial type II (AT2) cells leads to the release of heparin-binding epidermal growth factor-like growth factor (HB-EGF), which activates EGFR on fibroblasts, exacerbating lung injury pathology and reducing survival. Mechanistically, EGFR activation in fibroblasts induces the early growth response protein 1 (EGR1), which subsequently enhances chemokine C-X-C motif ligand 1 (CXCL1) secretion 24 h post-exposure, promoting neutrophil infiltration in the lung. RNA sequencing analysis corroborates these findings. Notably, pharmacological inhibition of EGFR phosphorylation using Erlotinib (ERL) significantly mitigates the inflammatory response in RT-induced ALI. These results not only illuminate the immune response in lung tissue but also highlight EGFR signaling in fibroblasts as a pivotal mediator of RT-induced ALI. This study identifies a novel therapeutic strategy targeting EGFR signaling in fibroblasts for the treatment of inflammatory lung diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, the Fifth Medical Center of PLA General Hospital, Beijing, 100039, China.
- Graduate School of PLA General Hospital, Beijing, 100853, China.
- State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, 100071, China.
- State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, 100071, China. yhy80324@163.com.
- Department of Clinical Laboratory, the Fifth Medical Center of PLA General Hospital, Beijing, 100039, China. 15300085578@163.com.
ORCID-Profile: Boan Li
Förderung
- he State Key Laboratory of Pathogen and Biosecurity
Zitieren
APA
Wang, Y., Zhu, X., Li, L., Su, D., Ai, L., Xie, H., Zhou, D., Yang, H., & Li, B. (2025). Fibroblast EGFR signaling mediates ricin toxin-induced acute lung injury via EGR1/CXCL1 axis. Archives of Toxicology, 99(8), 3413-3427. https://doi.org/10.1007/s00204-025-04067-3
Vancouver
Wang Y, Zhu X, Li L, Su D, Ai L, Xie H, et al. Fibroblast EGFR signaling mediates ricin toxin-induced acute lung injury via EGR1/CXCL1 axis. Archives of Toxicology. 2025;99(8):3413-3427. doi:10.1007/s00204-025-04067-3
BibTeX
@article{Wang2025,
author = {Wang, Yuqing and Zhu, Xiaoyu and Li, Lu and Su, Duo and Ai, Lingli and Xie, Hao and Zhou, Dongsheng and Yang, Huiying and Li, Boan},
title = {Fibroblast EGFR signaling mediates ricin toxin-induced acute lung injury via EGR1/CXCL1 axis},
journal = {Archives of Toxicology},
year = {2025},
volume = {99},
number = {8},
pages = {3413--3427},
doi = {10.1007/s00204-025-04067-3}
}
EUVIMED